LSD and psychedelics: a breakthrough in ADHD treatment or an illusion?
A recent review published in the International Journal of Molecular Sciences has turned the spotlight on a surprising possibility: psychedelics
Key points
Everyone knows it by its acronym, ADHD, and its full name, Attention Deficit Hyperactivity Disorder, encapsulates some of the salient features of this condition. But it is also true that reducing ADHD to simple distraction or hyperactivity is a big mistake. More and more neuroscientists describe it as a complex disorder of mental regulation: a brain that struggles to manage attention, impulses, motivation in a stable and productive way. And it can affect children as well as adults.
The available therapies also have obvious limitations. Today, treatment is mainly based on drugs such as Ritalin, together with cognitive-behavioural psychotherapy and psycho-educational courses. But research is already looking further afield. And a recent review published in the International Journal of Molecular Sciences has turned the spotlight on a surprising possibility: psychedelics.
Why LSD and psilocybin come into the picture
For years, ADHD experts have focused on dopamine and noradrenaline, the neurotransmitters that help the brain maintain concentration, self-control and continuity in daily activities. When these systems malfunction, symptoms very familiar to those living with ADHD appear: mind wandering here and there constantly, difficulty concentrating, constant search for immediate stimuli and enormous fatigue in performing repetitive or unrewarding activities.
In recent years, however, researchers have also begun to focus on another possible player: serotonin. And this is where LSD, psilocybin and ayahuasca come in.
Yes, the very substances associated with the psychedelic culture that influenced artists and music icons, from The Beatles to Pink Floyd, all the way to Steve Jobs (who certainly wasn't a musician), who called LSD one of the most important experiences of his life.

